Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar;20(1):219-226.
doi: 10.4314/ahs.v20i1.27.

Parvovirus B19 DNA detection in treatment-naïve HIV anemic patients in Lagos, Nigeria: a case control study

Affiliations

Parvovirus B19 DNA detection in treatment-naïve HIV anemic patients in Lagos, Nigeria: a case control study

Oluwaseyi Sedowhe Ashaka et al. Afr Health Sci. 2020 Mar.

Abstract

Background: Parvovirus B19 (B19) has tropism for cells of the erythroid lineage, which may lead to transient inhibition of erythropoiesis. Several studies and case reports suggested that B19 infection may contribute significantly to severe chronic anemia in HIV infected persons.

Objective: To detect parvovirus B19 DNA in treatment-naïve HIV patients.

Methods: This was a case control retrospective study. One hundred nineteen anemic and 81 non-anemic treatment-naïve HIV infected patients participated in the study at the Lagos University Teaching Hospital, Lagos, Nigeria. Polymerase chain reaction was used to detect B19 DNA.

Results: Out of 200 patients analysed, 13(6.5%) had parvovirus B19 DNA. Eight HIV patients with anemia had B19 DNA while five non-anemic HIV patients had B19 DNA. This suggests that the presence of B19 DNA in the blood of HIV positive individuals may contribute to anemia because the majority (61.5%) who were positive for B19 DNA had anemia as compared to the non-anemic control group (38.5%).

Conclusion: This study shows that the presence of B19 DNA in anemic HIV infected patients is not associated with chronic anaemia in HIV infection because no significant association exist.

Keywords: Parvovirus B19; anemia; human immunodeficiency virus; polymerase chain reaction.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Range value of CD4 counts in anemic case and non- anemic control subjects. Note: Figures in bracket are those who had detectable Parvovirus B19 DNA in their blood

References

    1. Slavov SN, Kashima S, Silva-Pinto AC, Covas DT. Human parvovirus B19. General considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions. Federation of European Microbiological Societies. 2011;62:247–262. - PubMed
    1. Young NS, Brown K E. Parvovirus B19. New England Journal of Medicine. 2004;350:586–597. - PubMed
    1. de Azevedo KM, Setúbal S, Camacho L A B, Velarde L G C, de Oliveira S A. Seroepidemiological study of human parvovirus B19 among human immunodeficiency virus-infected patients in a medium-sized city in Rio de Janeiro, Brazil. Oswaldo Cruz, Rio de Janeiro. 2009;104(6):901–904. - PubMed
    1. Heegaard E, Brown K. Human parvovirus B19. Clin Microbiol Rev. 2002;15:485–505. - PMC - PubMed
    1. Gallinella G. Parvovirus B19 Achievements and Challenges. ISRN Virology. 2013 33 pages.

MeSH terms

LinkOut - more resources